CRP appears to play a multifaceted role in the pathogenesis of AD, dementia, and cognitive dysfunction by promoting amyloid plaque formation, disrupting the blood–brain barrier and amplifying neuroinflammatory and vascular injury responses. The gene discussed is CRP; the disease is amyloidosis.